Scleroderma, Diffuse

6 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Scleroderma, Diffuse
Treatment and conditionWhere it standsTrials
Anti Thymocyte Globulin + GM-CSF + Total Body Irradiation + ALEMTUZUMAB + RITUXIMAB + HUMAN IMMUNOGLOBULIN G + Cyclophosphamide + THIOTEPA + Mesna for scleroderma, diffusePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Belimumab for scleroderma, diffusePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
MTX-474 for scleroderma, diffusePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
QEL-005 for scleroderma, diffusePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Telitacicept for scleroderma, diffusePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tulisokibart for scleroderma, diffusePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1